These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71. Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis. Hou J; Ju J; Zhang Z; Zhao C; Li Z; Zheng J; Sheng T; Zhang H; Hu L; Yu X; Zhang W; Li Y; Wu M; Ma H; Zhang X; He S Cell Death Dis; 2019 Jun; 10(7):493. PubMed ID: 31235688 [TBL] [Abstract][Full Text] [Related]
72. Combination of Allosteric and Orthosteric EGFR Inhibitors for Treating Non-Small-Cell Lung Cancer. Sabnis RW ACS Med Chem Lett; 2024 Mar; 15(3):342-343. PubMed ID: 38505844 [TBL] [Abstract][Full Text] [Related]
73. Investigation on the chemical space of the substituted triazole thio-benzoxazepinone RIPK1 inhibitors. Hao Y; Shao H; Qu Z; Li J; Shi Y; Zhang W; Yu J; Fu P; Zhuang C Eur J Med Chem; 2022 Jun; 236():114345. PubMed ID: 35398729 [TBL] [Abstract][Full Text] [Related]
74. Novel Adenosine Receptor Antagonists for Treating Cancer and Immune-Related Disorders. Sabnis RW ACS Med Chem Lett; 2023 Dec; 14(12):1619-1620. PubMed ID: 38116425 [TBL] [Abstract][Full Text] [Related]
75. Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity. Li Z; Hao Y; Yang C; Yang Q; Wu S; Ma H; Tian S; Lu H; Wang J; Yang T; He S; Zhang X Eur J Med Chem; 2022 Jan; 228():114036. PubMed ID: 34906762 [TBL] [Abstract][Full Text] [Related]
76. Discovery of 4-amino-1,6-dihydro-7H-pyrrolo[2,3-d]pyridazin-7-one derivatives as potential receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors. Zhang C; Chen Y; Li Y; Shi N; Teng Y; Li N; Tang M; Ma Z; Deng D; Chen L Eur J Med Chem; 2024 Feb; 265():116076. PubMed ID: 38171150 [TBL] [Abstract][Full Text] [Related]
77. Novel Heterocyclic Compounds for Treating Huntington's Disease. Sabnis RW; Sabnis AR ACS Med Chem Lett; 2024 Mar; 15(3):324-325. PubMed ID: 38505841 [TBL] [Abstract][Full Text] [Related]
78. Novel Serine-Arginine Protein Kinase Inhibitors for Treating Cancer. Sabnis RW ACS Med Chem Lett; 2023 May; 14(5):551-552. PubMed ID: 37197468 [TBL] [Abstract][Full Text] [Related]
79. 8-Aza Quinazolines as Brain Penetrant SOS1 Inhibitors for Treating Cancer. Sabnis RW ACS Med Chem Lett; 2023 Nov; 14(11):1487-1488. PubMed ID: 37974940 [TBL] [Abstract][Full Text] [Related]